ETFsBloomberg MSCI Sterling Liquid Corporate Screened & Tilted Index
Invesco

Invesco GBP Corporate Bond Screened & Tilted UCITS ETF Dist

IGBE LSEIrelandNot PEA-eligible
Last close · EUR
38.58EUR
+0.26% · +€0.10
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
IGBEBase
Fund charges
0.10%PRIIPs ongoing costs
Fund size
€215.8Mall share classes
Return 1Y
+7.1%
Sharpe 3Y
0.60
Volatility 1Y
5.3%annualised
Holdings
504Fund holdings

Performance

Compare
  • IGBE+7.1%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
IGBE+2.9%+2.3%+5.8%+4.8%+7.1%+22.3%-0.6%
MSCI World-2.8%-0.6%+7.8%+14.3%+14.1%+65.6%+64.8%
Gap to MSCI World+5.8%+2.9%-2.0%-9.4%-7.0%-43.3%-65.5%

Risk and return

Sharpe ratio · 3Y
0.60
Below MSCI World · 1.24
Return p.a.
+6.7%
Volatility
6.5%
Max loss
-7.5%Apr 2025

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
IGBE
0.60
CAC 40
0.37
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
5.2%
Holdings
504
As of
Fund holdings
  1. 1Morgan Stanley VAR 18/11/33XS25583898910.61%
  2. 2HSBC Holdings PLC VAR 16/11/34XS25535499030.57%
  3. 3E.ON International Finance BV 6.375% 07/06/32XS01485796660.53%
  4. 4Cooperatieve Rabobank UA 4.625% 23/05/29XS10698868410.50%
  5. 5Heathrow Funding Ltd 6.45% 10/12/31XS03830010530.50%
  6. 6MORGAN STANLEY VAR 10/09/32XS34074493400.50%
  7. 7Barclays PLC 3.25% 17/01/33XS17486990110.49%
  8. 8BARCLAYS PLC VAR 06/11/29XS27119458780.49%
  9. 9Barclays PLC VAR 14/11/32XS25523676870.49%
  10. 10Zurich Finance Ireland Designated VAR 23/11/52XS25239607190.49%

Countries

Not published · Country classification unavailable

Market cap

Weight vs holdings

5.2%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.